These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6202846)

  • 21. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF monoamine metabolites in depression and schizophrenia.
    Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The urinary ratio of 5-hydroxytryptophol to 5-hydroxyindole-3-acetic acid in surgical patients with chronic alcohol misuse.
    Spies CD; Herpell J; Beck O; Müller C; Pragst F; Borg S; Helander A
    Alcohol; 1999 Jan; 17(1):19-27. PubMed ID: 9895033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of 5-hydroxytryptophol as an alcohol intake marker.
    Helander A; Beck O; Borg S
    Alcohol Alcohol Suppl; 1994; 2():497-502. PubMed ID: 8974374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in HIV-1 infection.
    Kumar AM; Berger JR; Eisdorfer C; Fernandez JB; Goodkin K; Kumar M
    Neuropsychobiology; 2001; 44(1):13-8. PubMed ID: 11408787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence and distribution of 5-hydroxytryptophol in the rat.
    Cheifetz S; Warsh JJ
    J Neurochem; 1980 May; 34(5):1093-9. PubMed ID: 6154773
    [No Abstract]   [Full Text] [Related]  

  • 28. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
    Andreou D; Söderman E; Axelsson T; Sedvall GC; Terenius L; Agartz I; Jönsson EG
    Psychiatry Res; 2015 Sep; 229(1-2):497-504. PubMed ID: 26142836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder.
    Sullivan GM; Oquendo MA; Huang YY; Mann JJ
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):547-56. PubMed ID: 16259647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid liquid chromatographic determination of 5-hydroxyindoles and dihydroxyphenylacetic acid in cerebrospinal fluid of the rat.
    Le Quan-Bui KH; Elghozi JL; Devynck MA; Meyer P
    Eur J Pharmacol; 1982 Jul; 81(2):315-20. PubMed ID: 6180913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of 5-hydroxytryptophol and 5-hydroxyindoleacetic acid in human and rat brain and plasma.
    Beck O; Borg S; Jonsson G; Lundman A; Valverius P
    J Neural Transm; 1984; 59(1):57-67. PubMed ID: 6201590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women.
    Banki CM
    J Neural Transm; 1977; 41(2-3):135-43. PubMed ID: 915503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing melatonin, 5-hydroxytryptophol, 5-hydroxyindoleacetic acid, 5-hydroxytryptamine and tryptophan in rat pineal glands.
    Young SN; Anderson GM
    Neuroendocrinology; 1982 Dec; 35(6):464-8. PubMed ID: 6185873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Serotonin depression"--a biochemical subgroup within the affective disorders?
    Asberg M; Thorén P; Träskman L; Bertilsson L; Ringberger V
    Science; 1976 Feb; 191(4226):478-80. PubMed ID: 1246632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma total cholesterol concentrations do not predict cerebrospinal fluid neurotransmitter metabolites: implications for the biophysical role of highly unsaturated fatty acids.
    Hibbeln JR; Umhau JC; George DT; Shoaf SE; Linnoila M; Salem N
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):331S-8S. PubMed ID: 10617992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid correlates of depression in Huntington's disease.
    Kurlan R; Caine E; Rubin A; Nemeroff CB; Bissette G; Zaczek R; Coyle J; Spielman FJ; Irvine C; Shoulson I
    Arch Neurol; 1988 Aug; 45(8):881-3. PubMed ID: 2456053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraspinal pressure influences CSF disposition of tryptophan and 5-HIAA.
    Eklundh T; Nordin C
    Neuropsychobiology; 2001; 44(2):84-7. PubMed ID: 11490176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indolic substances in plasma, cerebrospinal fluid, and frontal cortex of human subjects infused with saline or tryptophan.
    Gillman PK; Bartlett JR; Bridges PK; Hunt A; Patel AJ; Kantamaneni BD; Curzon G
    J Neurochem; 1981 Aug; 37(2):410-7. PubMed ID: 6167678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
    Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.